Building the Invisible Infrastructure - Why Biotech Needs Ecosystems

Explore the critical infrastructure challenges preventing biotechnology breakthroughs from reaching market in this hour-long conversation with synthetic biologist and strategic advisor Nadine Bongaerts. Discover why despite revolutionary scientific capabilities like CRISPR gene editing, synthetic biology cell programming, and biomanufacturing alternatives to petrochemicals, promising biotech innovations still take decades to commercialize or die in the "valley of death" between laboratory and market. Learn how the real bottleneck isn't research and development anymore, but rather the invisible infrastructure of ecosystems, regulations, supplier networks, talent acquisition, and consumer acceptance that determines which technologies succeed. Examine the specific challenges highly innovative biotech companies face when seeking suppliers, understand the talent paradox affecting the industry, and analyze why consumer trust rather than technological advancement will ultimately decide biotechnology's future. Gain insights from Bongaerts' experience as former Chief Innovation Officer at cultured meat company Gourmey, where she led the company from R&D through production scale-up and navigated the first-ever EU regulatory submission for cultivated meat, and her current work at Amplicon Advisors building the connective tissue that transforms scientific possibility into economic reality. Understand what biotechnology and synthetic biology truly encompass, why these fields are more crucial than ever, what aspects are genuinely new versus established, and why biomanufacturing should become the standard rather than the exception, making this essential viewing for anyone involved in shaping the future of breakthrough biotechnologies.